Skip to main content
16489 search results for:

Diffuse Large B-Cell Lymphoma 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 20-04-2024 | Diffuse Large B-Cell Lymphoma | Online First

    Diffuse Large B Cell Lymphoma (DLBCL) Presenting Clinically as a Large Ulceroproliferative Mass

  2. 06-05-2024 | Dermatomyositis | Online First

    Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma

    Older adults with dermatomyositis positive for anti-transcription intermediary factor 1-gamma (anti-TIF-1γ) antibodies have a high risk of malignancies, including hematologic malignancies such as lymphoma. Here, we present a case of …

  3. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma

    The significance of Protein phosphatase 4 catalytic subunit (PPP4C) in diffuse large B-cell lymphoma (DLBCL) prognosis is not well understood. This work aimed to investigate the expression of PPP4C in DLBCL, investigate the correlation between …

  4. 24-04-2024 | Diffuse Large B-Cell Lymphoma | Online First

    Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?

    Diffuse large B-cell lymphoma (DLBCL) is a curable disease with variable outcomes due to underlying heterogeneous clinical and molecular features—features that are insufficiently characterized with our current tools. Due to these limitations …

  5. 11-03-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement

    BCL6-rearrangement (BCL6-R) is associated with a favorable prognosis of follicular lymphoma (FL), but the mechanism is unknown. We analyzed the clinicopathological, immune microenvironment (immune checkpoint, immuno-oncology markers), and …

  6. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma

    Follicular lymphoma (FL) is a malignant counterpart of normal germinal center B-cells, which is the second most common lymphoma behind diffuse large B cell lymphoma (DLBCL) [ 1 ]. Translocation of t(14;18) is a common event which is detected in …

  7. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma

    About 16% of human cancers are linked to infectious agents, predominantly due to viral and bacterial infections [ 1 ]. Chronic hepatitis C (CHC) virus infection, primarily affecting the liver, also poses systemic risks, significantly increasing the …

  8. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation

    Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, which accounts for about 30–58% of NHL [ 1 ]. In the era of new drugs for tumor treatment, such as anthracyclines and monoclonal anti-CD20 antibody, the prognosis of …

  9. 08-04-2024 | Diffuse Large B-Cell Lymphoma | Online First

    Maxillary Diffuse Large B-Cell Lymphoma Enshrouded as Osteomyelitis: A Case Report

    Extranodal non-Hodgkin’s lymphoma (NHL) afflicting the head and neck region is rare, accounting for only about 5%. Diffuse large B-cell lymphoma (DLBCL) is the most common type of NHL affecting the oral cavity. Due to its variable clinical …

  10. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database

    DLBCL, known as diffuse large B-cell lymphoma, is a highly heterogeneous disease and is the most common type of non-Hodgkin’s lymphoma, accounting for approximately 30–40% of all lymphoma cases [ 1 ]. While there have been significant advancements …

  11. 21-04-2024 | Diffuse Large B-Cell Lymphoma | Online First

    Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes

    Genetic heterogeneity inherent to diffuse large B-cell lymphoma (DLBCL) is a predominant factor contributing to variations in treatment outcomes. Multiple classification systems rooted in genetic alterations have been proposed, such as the …

  12. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma

    Advanced diffuse large B cell lymphoma (DLBCL) is a common malignant tumor with aggressive clinical features and poor prognosis. At present, there is lack of effective prognostic tool for patients with advanced (stage III/IV) DLBCL. The aim of …

  13. 03-01-2024 | Splenectomy | OriginalPaper

    Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database

    Despite being the most common primary tumor of the spleen, in the past, few studies have predicted the prognosis of primary spleen diffuse large B cell lymphoma. This study aimed to establish a nomogram prediction model of overall survival in …

  14. Open Access 30-03-2024 | Diffuse Large B-Cell Lymphoma | Online First

    The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma (NHL), with recent data suggesting that it accounts for approximately 30% of all new NHL cases globally each year [ 1 ]. It is worth noting that up to 40% of …

  15. Open Access 01-12-2024 | Epstein-Barr Virus | OriginalPaper

    Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing

    Intraocular lymphoma is a rare type of ocular malignancy and has two types: primary and secondary. Primary intraocular lymphoma (PIOL), a subset of primary central system lymphoma (PCNSL), affects the vitreous, retina, iris, ciliary body, choroid …

  16. 19-03-2024 | Human Immunodeficiency Virus | Online First

    Synchronous Anal Squamous Cell Carcinoma and Diffuse Large B Cell Lymphoma of Stomach: the First Report of an Odd Couple

    The unique case study presented here explores an exceptionally rare occurrence in an HIV-positive female—synchronous diagnoses of anal squamous cell carcinoma and diffuse large B cell lymphoma (DLBCL) of the stomach. With limited existing …

  17. Open Access 01-12-2024 | Diffuse Large B-Cell Lymphoma | Letter

    Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma. A major mutagenic process in DLBCL is aberrant somatic hypermutation (aSHM) by activation-induced cytidine deaminase (AID), which occurs preferentially at RCH/TW sequence motifs …

  18. 30-01-2024 | Diffuse Large B-Cell Lymphoma | Letter

    Diffuse large B-cell lymphoma of the skull vault

  19. 16-03-2024 | Diffuse Large B-Cell Lymphoma | Online First

    Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio

    We conducted a multi-institutional retrospective study in 100 transplant-ineligible (TI) patients with diffuse large B-cell lymphoma (DLBCL) that relapsed or progressed after first-line R-CHOP (or -like) therapy to develop a robust predictive …

  20. 16-01-2024 | Diffuse Large B-Cell Lymphoma | OriginalPaper

    Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century

    Diffuse large B-cell lymphoma (DLBCL) is a severe non-Hodgkin’s lymphoma. Life expectancy has improved with rituximab, but cause-specific mortality data is lacking. Using the Surveillance, Epidemiology, and End Results (SEER) database to study …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.